Aurora Cannabis (ACB)
Produces medical cannabis internationally while operating North American plant-propagation businesses.
Something off on this page? Send us feedback.
Produces, distributes, and sells medical cannabis in Canada and international markets, while consumer cannabis is limited in Canada. It also operates plant-propagation businesses added through the Thrive and Bevo acquisitions; international medical products include Farm Gas and Driftwood Diesel.
Produces, distributes, and sells medical cannabis in Canada and international markets, with consumer cannabis limited to Canada. Its cultivation and distribution footprint supports medical products including Farm Gas and Driftwood Diesel.
International medical markets are central to the operating model: listed products reach Germany, Poland, the United Kingdom, Canada, and Australia. Plant-propagation operations joined the structure through the Thrive and Bevo transactions, adding a second business line alongside cannabis.
Recent investments extend medical-cannabis capacity, including full ownership of MedReleaf Australia and the Safari Flower acquisition. The business depends on regulated medical-cannabis regimes and EU-GMP-certified cultivation and manufacturing capacity used to serve international markets.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
No analyst notes in the last 24 months.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $106.2M · Total debt $16.2M · Total assets $442.2M · Shareholders' equity $375.4M
- Revenue
- $48.1M
- Operating income
- −$33.8M
- Net income
- −$2.9M
Reported in CAD, converted at the latest exchange rate
No dividends on record.
| Institutions | ≈ 8.88% | 5.23M ADS | |
|---|---|---|---|
| 158 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Other | ≈ 91.12% | 53.71M ADS | |
| remainder | |||
58.95M ADS as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Goldman Sachs Group IncInstitution | 2.29% | 1.35M ADS | as of Jun 30, 2026 |
Toroso Investments, LLCInstitution | 2.15% | 1.26M ADS | as of Jun 30, 2026 |
Renaissance Technologies LLCInstitution | 1.33% | 784,955 ADS | as of Jun 30, 2026 |
National Bank of Canada /FI/Institution | 0.41% | 241,055 ADS | as of Jun 30, 2026 |
Morgan StanleyInstitution | 0.41% | 240,698 ADS | as of Jun 30, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- Tilray Brands
Global medical and adult-use cannabis supplier with broad Canadian formats
- Canopy Growth
Medical and adult-use cannabis supplier across Canada, Europe and Australia
- Cronos Group
Canadian and international cannabis brands spanning medical and adult use
- Organigram Global
Canadian indoor-grown medical and adult-use cannabis producer with EU reach
- Village Farms International
Canadian greenhouse cannabis producer with Pure Sunfarms and export capacity
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Aurora Cannabis | $4.06 | +0.62% | $249.6M | — | — | 1.2 | −34.0% |
| Tilray Brands | $4.19 | +2.65% | $456.3M | — | — | 0.4 | +25.5% |
| Canopy Growth | $0.9274 | +0.39% | $390.0M | — | — | 1.7 | −20.8% |
| Cronos Group | $3.37 | +1.20% | $1.24B | 18.4 | 56.2 | 5.1 | +58.4% |
| Organigram Global | $1.12 | −0.45% | $157.7M | 2.5 | 37.2 | 0.7 | +43.2% |
| Village Farms International | $3.09 | +7.29% | $350.8M | 15.3 | 15.6 | 1.5 | +6.8% |
| Median | 15.3 | 37.2 | 1.5 | +25.5% |